IGC Pharma (IGC) Operating Expenses (2010 - 2025)
IGC Pharma (IGC) posted quarterly Operating Expenses of $3.0 million for Q3 2025, up 53.12% year-over-year from $2.0 million in Q3 2024, and up 45.6% quarter-over-quarter from $2.1 million in Q2 2025.
IGC Pharma (IGC) Operating Expenses (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported Operating Expenses for 16 consecutive years, with $3.0 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Operating Expenses rose 53.12% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $5.1 million (down 37.3% YoY), while the FY2026 annual figure was $2.5 million, down 68.84% from the prior year.
- Operating Expenses advanced to $3.0 million in Q3 2025 per IGC's latest filing, from $2.1 million in the prior quarter.
- Across five years, Operating Expenses topped out at $6.6 million in Q1 2022 and bottomed at $1.6 million in Q1 2025.
- Historically, Operating Expenses has averaged $2.8 million across 5 years, with a median of $2.6 million in 2024.
- Annual changes were most pronounced in 2021 — Operating Expenses jumped 157.7% — and 2024, when it slumped 42.93%.
- IGC Pharma's Operating Expenses stood at $2.4 million in 2021, then decreased by 2.74% to $2.4 million in 2022, then soared by 31.55% to $3.1 million in 2023, then plunged by 36.7% to $2.0 million in 2024, then surged by 51.26% to $3.0 million in 2025.
- Business Quant data shows IGC's Operating Expenses at $3.0 million in Q3 2025, $2.1 million in Q2 2025, and $1.6 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 2.06 Mn |
| Mar 31, 2025 | 1.57 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Jun 30, 2024 | 2.56 Mn |
| Mar 31, 2024 | 2.34 Mn |
| Dec 31, 2023 | 3.13 Mn |
| Sep 30, 2023 | 2.67 Mn |
| Jun 30, 2023 | 2.39 Mn |
| Mar 31, 2023 | 4.10 Mn |
| Dec 31, 2022 | 2.38 Mn |
| Sep 30, 2022 | 2.62 Mn |
| Jun 30, 2022 | 2.94 Mn |
| Mar 31, 2022 | 6.57 Mn |
| Dec 31, 2021 | 2.45 Mn |
| Sep 30, 2021 | 4.39 Mn |
| Jun 30, 2021 | 2.22 Mn |
| Mar 31, 2021 | 2.82 Mn |
| Dec 31, 2020 | 2.34 Mn |